Research Progress of Exosomes-derived Long Non-coding RNA in Bladder Cancer

Jun GU; Zexi HE; Ting LUAN; Haifeng WANG; Jiansong WANG; Mingxia DING

doi:10.12259/j.issn.2095-610X.S20220110

Volume 43 Issue 1

Jan. 2022

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2022 > 43(1): 150-156

Jun GU, Zexi HE, Ting LUAN, Haifeng WANG, Jiansong WANG, Mingxia DING. Research Progress of Exosomes-derived Long Non-coding RNA in Bladder Cancer[J]. Journal of Kunming Medical University, 2022, 43(1): 150-156. doi: 10.12259/j.issn.2095-610X.S20220110

Citation:

Jun GU, Zexi HE, Ting LUAN, Haifeng WANG, Jiansong WANG, Mingxia DING. Research Progress of Exosomes-derived Long Non-coding RNA in Bladder Cancer[J]. Journal of Kunming Medical University, 2022, 43(1): 150-156. doi: 10.12259/j.issn.2095-610X.S20220110

Citation:

PDF( 567 KB)

Research Progress of Exosomes-derived Long Non-coding RNA in Bladder Cancer

doi: 10.12259/j.issn.2095-610X.S20220110

Dept. of Urology，The 2nd Affiliated Hospital of Kunming Medical University， Yunnan Institute of Urology，Kunming Yunnan 650101，China

Received Date: 2021-10-07
Available Online: 2021-12-20
Publish Date: 2022-01-15

Abstract

Abstract

Bladder cancer is one of the most common urinary tumors with the high morbidity and recurrence rate. It is of great clinical value to develop a non-invasive detection technique with the high sensitivity and specificity in vitro for the diagnosis and treatment of bladder cancer. Exosomes are extracellular vesicles secreted by many cells and play a key role in intercellular communication by delivering intracellular signaling substances （such as proteins, nucleic acids, non-coding RNAs, etc.）. More and more studies have shown that exosomes-derived long non-coding RNA plays an important regulatory role in the development and progression of bladder cancer and can effectively reflect the progression and prognosis of tumors, which is expected to become a new tumor marker. Therefore, this paper reviews the research progress of exosomes-derived long non-coding RNA in the development and diagnosis of bladder cancer.
- Exosomes,
- Long non-coding RNA,
- Bladder cancer

FullText(HTML)

References(50)

References

[1]	Kelly J D,Tan W S,Porta N,et al. BOXIT-A randomised phase III placebo-controlled trial evaluating the addition of celecoxib to standard treatment of transitional cell carcinoma of the bladder (CRUK/07/004)[J]. Eur Urol,2019,75(4):593-601. doi: 10.1016/j.eururo.2018.09.020
[2]	Tan W S,Tan W P,Tan M Y,et al. Novel urinary biomarkers for the detection of bladder cancer:A systematic review[J]. Cancer Treat Rev,2018,69(3):39-52.
[3]	Babjuk M,Bohle A,Burger M,et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder:Update 2016[J]. Eur Urol,2017,71(3):447-461. doi: 10.1016/j.eururo.2016.05.041
[4]	Kamat A M,Hahn N M,Efstathiou J A,et al. Bladder cancer[J]. Lancet,2016,388(10061):2796-2810. doi: 10.1016/S0140-6736(16)30512-8
[5]	Lokeshwar V B, Habuchi T, Grossman H B, et al. Bladder tumor markers beyond cytology: International consensus panel on bladder tumor markers[J]. Urology, 2005, 66（6 Suppl 1）: 35-63.
[6]	Chao D,Freedland S J,Pantuck A J,et al. Bladder cancer 2000:Molecular markers for the diagnosis of transitional cell carcinoma[J]. Rev Urol,2001,3(2):85-93.
[7]	Nabet B Y, Qiu Y, Shabason J E, et al. Exosome RNA unshielding couples stromal activation to pattern recognition receptor signaling in cancer[J]. Cell, 2017, 170（2）: 352-366 e313.
[8]	Jiang L,Vader P,Schiffelers R M. Extracellular vesicles for nucleic acid delivery:Progress and prospects for safe RNA-based gene therapy[J]. Gene Ther,2017,24(3):157-166. doi: 10.1038/gt.2017.8
[9]	Navakanitworakul R,Hung W T,Gunewardena S,et al. Characterization and small RNA content of extracellular vesicles in follicular fluid of developing bovine antral follicles[J]. Sci Rep,2016,6(9):25486.
[10]	Tkach M,Thery C. Communication by extracellular vesicles:Where we are and where we need to go[J]. Cell,2016,164(6):1226-1232. doi: 10.1016/j.cell.2016.01.043
[11]	Li M,Zeringer E,Barta T,et al. Analysis of the RNA content of the exosomes derived from blood serum and urine and its potential as biomarkers[J]. Philos Trans R Soc Lond B Biol Sci,2014,369(1652):20130502. doi: 10.1098/rstb.2013.0502
[12]	Zhou W,Fong M Y,Min Y,et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis[J]. Cancer Cell,2014,25(4):501-515. doi: 10.1016/j.ccr.2014.03.007
[13]	Yang L,Wu X H,Wang D,et al. Bladder cancer cell-derived exosomes inhibit tumor cell apoptosis and induce cell proliferation in vitro[J]. Mol Med Rep,2013,8(4):1272-1278. doi: 10.3892/mmr.2013.1634
[14]	Xu X D,Wu X H,Fan Y R,et al. Exosome-derived microRNA-29c induces apoptosis of BIU-87 cells by down regulating BCL-2 and MCL-1[J]. Asian Pac J Cancer Prev,2014,15(8):3471-3476. doi: 10.7314/APJCP.2014.15.8.3471
[15]	Beckham C J,Olsen J,Yin P N,et al. Bladder cancer exosomes contain EDIL-3/Del1 and facilitate cancer progression[J]. J Urol,2014,192(2):583-592. doi: 10.1016/j.juro.2014.02.035
[16]	Ringuette Goulet C,Bernard G,Tremblay S,et al. Exosomes induce fibroblast differentiation into cancer-associated fibroblasts through TGFβ signaling[J]. Mol Cancer Res,2018,16(7):1196-1204. doi: 10.1158/1541-7786.MCR-17-0784
[17]	Franzen C A,Blackwell R H,Todorovic V,et al. Urothelial cells undergo epithelial-to-mesenchymal transition after exposure to muscle invasive bladder cancer exosomes[J]. Oncogenesis,2015,4(8):e163. doi: 10.1038/oncsis.2015.21
[18]	Goulet C R,Champagne A,Bernard G,et al. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling[J]. BMC Cancer,2019,19(1):137. doi: 10.1186/s12885-019-5353-6
[19]	Shan G,Zhou X,Gu J,et al. Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/beta-catenin pathway and upregulating PTEN[J]. Cell Oncol (Dordr),2021,44(1):45-59. doi: 10.1007/s13402-020-00500-0
[20]	Jeppesen D K,Nawrocki A,Jensen S G,et al. Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors[J]. Proteomics,2014,14(6):699-712. doi: 10.1002/pmic.201300452
[21]	Pan J,Li X,Wu W,et al. Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells[J]. Cancer Lett,2016,382(1):64-76. doi: 10.1016/j.canlet.2016.08.015
[22]	Yang C,Li X,Wang Y,et al. Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells[J]. Gene,2012,496(1):8-16. doi: 10.1016/j.gene.2012.01.012
[23]	Wang X,Gong Y,Jin B,et al. Long non-coding RNA urothelial carcinoma associated 1 induces cell replication by inhibiting BRG1 in 5637 cells[J]. Oncol Rep,2014,32(3):1281-1290. doi: 10.3892/or.2014.3309
[24]	Wang X-S,Zhang Z,Wang H-C,et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma[J]. Clin Cancer Res,2006,12(16):4851-4858. doi: 10.1158/1078-0432.CCR-06-0134
[25]	Wang F,Li X,Xie X,et al. UCA1,a non-protein-coding RNA up-regulated in bladder carcinoma and embryo,influencing cell growth and promoting invasion[J]. FEBS Lett,2008,582(13):1919-1927. doi: 10.1016/j.febslet.2008.05.012
[26]	Xue M,Chen W,Xiang A,et al. Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1[J]. Mol Cancer,2017,16(1):143. doi: 10.1186/s12943-017-0714-8
[27]	Xue M,Pang H,Li X,et al. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway[J]. Cancer Sci,2016,107(1):18-27. doi: 10.1111/cas.12844
[28]	Zheng R,Du M,Wang X,et al. Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression[J]. Mol Cancer,2018,17(1):143. doi: 10.1186/s12943-018-0880-3
[29]	Huang C S,Ho J Y,Chiang J H,et al. Exosome-derived LINC00960 and LINC02470 promote the epithelial-mesenchymal transition and aggressiveness of bladder cancer cells[J]. Cells,2020,9(6):1419. doi: 10.3390/cells9061419
[30]	Yan L,Wang P,Fang W,et al. Cancer-associated fibroblasts-derived exosomes-mediated transfer of LINC00355 regulates bladder cancer cell proliferation and invasion[J]. Cell Biochem Funct,2020,38(3):257-265. doi: 10.1002/cbf.3462
[31]	He W,Zhong G,Jiang N,et al. Long noncoding RNA BLACAT2 promotes bladder cancer-associated lymphangiogenesis and lymphatic metastasis[J]. J Clin Invest,2018,128(2):861-875. doi: 10.1172/JCI96218
[32]	Chen C,He W,Huang J,et al. LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment[J]. Nat Commun,2018,9(1):3826. doi: 10.1038/s41467-018-06152-x
[33]	Chen C,Luo Y,He W,et al. Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer[J]. J Clin Invest,2020,130(1):404-421.
[34]	Ren H,Yang X,Yang Y,et al. Upregulation of LncRNA BCYRN1 promotes tumor progression and enhances EpCAM expression in gastric carcinoma[J]. Oncotarget,2017,9(4):4851-4861.
[35]	Huo W,Qi F,Wang K. Long non-coding RNA BCYRN1 promotes prostate cancer progression via elevation of HDAC11[J]. Oncol Rep,2020,44(3):1233-1245.
[36]	Lang N,Wang C,Zhao J,et al. Long non-coding RNA BCYRN1 promotes glycolysis and tumor progression by regulating the miR-149/PKM2 axis in non-small-cell lung cancer[J]. Mol Med Rep,2020,21(3):1509-1516.
[37]	Yu J H,Chen Y. Clinical significance of lncRNA BCYRN1 in colorectal cancer and its role in cell metastasis[J]. Eur Rev Med Pharmacol Sci,2019,23(21):9371-9378.
[38]	Ghafouri Fard S,Dashti S,Hussen B M,et al. BCYRN1:An oncogenic lncRNA in diverse cancers[J]. Pathol Res Pract,2021,220(4):153385.
[39]	Zheng H,Chen C,Luo Y,et al. Tumor-derived exosomal BCYRN1 activates WNT5A/VEGF-C/VEGFR3 feedforward loop to drive lymphatic metastasis of bladder cancer[J]. Clin Transl Med,2021,11(7):e497.
[40]	Luo G,Zhang Y,Wu Z,et al. Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell resistance to cisplatin by regulating miR-34b-5p/ABCB1 axis[J]. Acta Biochim Biophys Sin (Shanghai),2021,53(5):558-566. doi: 10.1093/abbs/gmab023
[41]	Crowley E,Di Nicolantonio F,Loupakis F,et al. Liquid biopsy:monitoring cancer-genetics in the blood[J]. Nat Rev Clin Oncol,2013,10(8):472-484. doi: 10.1038/nrclinonc.2013.110
[42]	Su Q,Wu H,Zhang Z,et al. Exosome-Derived Long Non-Coding RNAs as Non-Invasive Biomarkers of Bladder Cancer[J]. Front Oncol,2021,11(15):719863.
[43]	Li W X,Zhang Y L. Novel long non-coding RNA markers for prognostic prediction of patients with bladder cancer[J]. Chin Med Sci J,2020,35(3):239-247. doi: 10.24920/003662
[44]	Zhang S,Du L,Wang L,et al. Evaluation of serum exosomal LncRNA-based biomarker panel for diagnosis and recurrence prediction of bladder cancer[J]. J Cell Mol Med,2019,23(2):1396-1405. doi: 10.1111/jcmm.14042
[45]	Zhan Y,Du L,Wang L,et al. Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer[J]. Mol Cancer,2018,17(1):142. doi: 10.1186/s12943-018-0893-y
[46]	Yazarlou F,Modarressi M H,Mowla S J,et al. Urinary exosomal expression of long non-coding RNAs as diagnostic marker in bladder cancer[J]. Cancer Manag Res,2018,10(22):6357-6365.
[47]	Abbastabar M,Sarfi M,Golestani A,et al. Tumor-derived urinary exosomal long non-coding RNAs as diagnostic biomarkers for bladder cancer[J]. EXCLI J,2020,19(1):301-310.
[48]	Wang J,Gao Y,Wang X,et al. Circulating lncRNAs as noninvasive biomarkers in bladder cancer:A diagnostic meta-analysis based on 15 published articles[J]. Int J Biol Markers,2020,35(2):40-48. doi: 10.1177/1724600820926685
[49]	Wang J,Yang K,Yuan W,et al. Determination of serum exosomal H19 as a noninvasive biomarker for bladder cancer diagnosis and prognosis[J]. Med Sci Monit,2018,24(12):9307-9316.
[50]	Berrondo C,Flax J,Kucherov V,et al. Expression of the long non-coding RNA HOTAIR correlates with disease progression in bladder cancer and is contained in bladder cancer patient urinary exosomes[J]. PLoS One,2016,11(1):e0147236. doi: 10.1371/journal.pone.0147236

Relative Articles(20)

Relative Articles

[1]	Yuqin LIU, Mingying YANG, Liufang WANG, Siya XIA, Danna LI, Xijuan ZHAO, Ya WANG. Development of a Patient-reported Outcome Scale For Bladder Cancer and Test of Reliability and Validity. Journal of Kunming Medical University, 2024, 45(7): 183-190. doi: 10.12259/j.issn.2095-610X.S20240727
[2]	Yijun AN, Lidan YU, Meisu ZHAO, Dongmei MA, Chunhua YANG, Yao KONG. The Application of Prognostic Model of Lysosomal Related Genes in Bladder Cancer. Journal of Kunming Medical University, 2024, 45(5): 66-72. doi: 10.12259/j.issn.2095-610X.S20240510
[3]	Feifei XIE, Yinzi XIN, Min XU, Jinghan LI, Wei WANG. Mechanisms of Long Non-Coding RNAs in Cartilage Development and Related Diseases. Journal of Kunming Medical University, 2024, 45(10): 1-7. doi: 10.12259/j.issn.2095-610X.S20241001
[4]	Jun XIE, Shaoyou LIU, Hongjin SHI, Qiuyu MAO, Hong YANG. Enhanceing Effect of EZH2 Inhibitors in Combination with GC Chemotherapeutic Agents in Bladder Cancer. Journal of Kunming Medical University, 2023, 44(10): 67-76. doi: 10.12259/j.issn.2095-610X.S20231017
[5]	Shi CHEN, Shi FU, Zhiyong TAN, Jiansong WANG, Haifeng WANG. Research Progress of Autophagy in the Development and Treatment of Bladder Cancer. Journal of Kunming Medical University, 2023, 44(5): 168-174. doi: 10.12259/j.issn.2095-610X.S20230503
[6]	Liang ZHANG, Baoquan WANG, Xifeng LEI, Xu WANG, Yang KE, Wei ZHANG. M2 Macrophage-derived Exosome miR-1246 Regulates the Growth and Invasion of Gastric Cancer Cells. Journal of Kunming Medical University, 2023, 44(7): 69-77. doi: 10.12259/j.issn.2095-610X.S20230724
[7]	Shijie CAO, Hongwei AN. Mechanism and Progress of MSC Derived Extracellular Vesicles in the Treatment of Ischemic Stroke. Journal of Kunming Medical University, 2023, 44(9): 155-160. doi: 10.12259/j.issn.2095-610X.S20230913
[8]	Haonan DONG, Haifeng WANG, Yinglong HUANG, Hongjin SHI, Lan MAO, Yijie LIU, Jiansong WANG. A Review on Metabolic Complications and Management after Radical Cystectomy and Orthotopic Neoblastectomy. Journal of Kunming Medical University, 2022, 43(12): 159-163. doi: 10.12259/j.issn.2095-610X.S20221229
[9]	Zhi YAN, Jingang HAO, Yunyun SHANG. Value of VI-RADS Scoring System in Precision Treatment of Bladder Cancer. Journal of Kunming Medical University, 2022, 43(3): 74-79. doi: 10.12259/j.issn.2095-610X.S20220322
[10]	Fangyuan GUO, Wenliang LI, Fan XU, Xiangqun WEI. The Expression and Clinical Significance of Non-coding RNA in Cervical Cancer. Journal of Kunming Medical University, 2022, 43(5): 108-116. doi: 10.12259/j.issn.2095-610X.S20220527
[11]	Tianhong ZHANG, Hongju YANG. Research Progress of Exosomal miRNA in Hepatocellular Carcinoma. Journal of Kunming Medical University, 2022, 43(2): 150-153. doi: 10.12259/j.issn.2095-610X.S20220221
[12]	Li-ya MA, Nan-quan RAO, He-feng YANG. Research Progress of Mesenchymal Stem Cell Exosomes in Oral Tissue Regeneration. Journal of Kunming Medical University, 2021, 42(5): 147-153. doi: 10.12259/j.issn.2095-610X.S20210527
[13]	Xiao CAI, Xue-tao YI, Jing-qing YAO, Xin-yu DAI, Zhong-quan TANG, Ting OU, Xiao-min ZHAO, Yun-tao LI. The Regulation of Exosome Derived from Human Bone Marrow Mesenchymal Stem Cells on the Polarization of Glioma-associated Macrophages. Journal of Kunming Medical University, 2021, 42(1): 38-45. doi: 10.12259/j.issn.2095-610X.S20210101
[14]	Teng-fei ZHANG, Yue-feng HE, Lei ZHANG, Li ZHANG, Kai-yun YANG, Lian-qing LIU, Hui TAN. Expression of Long Non-coding RNA APTR，HEIH，FAS-ASA1，FAM83H-AS1，DICER1-AS1，PR-lncRNA in Lung Cancer. Journal of Kunming Medical University, 2021, 42(4): 49-52. doi: 10.12259/j.issn.2095-610X.S20210409
[15]	Yu Xiao Dong , Long Jiang . . Journal of Kunming Medical University, 2019, 40(09): 68-71.
[16]	Yang Can , Gong Yu Hang , Wang Hai Feng , Li Hai Hao , Liu Jing Yu , Wang Wei , Wang Jian Song , Zuo Yi Gang , Chen Jian , Zhan Hui , Ding Ming Xia . The Research of Monoclonal Antibody KMP1 Inhibited Bladder Cancer EJ Cell Lines Growth and Metastasis in Vivo. Journal of Kunming Medical University, 2018, 39(05): 1-6.
[17]	Lei Yu Ying , Gao Jie , Wang Rao Xiang , Chuan Li Xue , Hao Jin Gang . Value of Diffusion Weighted Imaging in the Diagnosis of Bladder Cancer. Journal of Kunming Medical University, 2017, 38(07): 136-139.
[18]	Huang Zhen Hua , Shi Xin , Wang Hui Tao , Zhang Jing Song , Wang Guang , Hao Jin Gang , Liu Jian He . Application Value of DWI in Diagnosis of T Staging of Bladder Cancer. Journal of Kunming Medical University, 2016, 37(12): 67-71.
[19]	Ma Zhen . . Journal of Kunming Medical University, 2012, 33(07): 1-1.
[20]	. . Journal of Kunming Medical University,